TY - JOUR
T1 - Core and penumbral nitric oxide synthase activity during cerebral ischemia and reperfusion in the rat pup
AU - Ashwal, Stephen
AU - Tone, Beatriz
AU - Tian, Hui Rou
AU - Cole, Daniel J.
AU - Liwnicz, Boleslaw H.
AU - Pearce, William J.
N1 - Pediatr Res. 1999 Oct;46(4):390-400. Research Support, Non-U.S. Gov't
PY - 1999/10
Y1 - 1999/10
N2 - Our studies examined the hypothesis that the distribution of cerebral injury after a focal ischemic insult in the immature rat pup is associated with the regional distribution of nitric oxide synthase (NOS) activity and that differences in the vulnerability to ischemia between pup and adult might be related to differences in cofactor availability. We measured NOS activity in well-defined regions prone to become either core or penumbra in controls and at different times (end of occlusion, 0.5 h, and 24 h reperfusion) after middle cerebral artery occlusion (MCAO) from the right and left hemispheres in a 14- to 18-day-old rat pup filament model. Three groups of corresponding isoflurane sham controls were also included. 'Core' NOS activity for combined right and left hemispheres ranged from 113% to 217% more than 'penumbral' regions in control and sham groups. In the three MCAO groups, marked decreases in ischemic core and penumbral NOS activity were seen; however, core NOS remained higher than penumbral regions bilaterally. The effects of cofactor addition (10 μM tetrahydrobiopterin, 3 μM flavin adenine dinucleotide, and 3 μM flavin mononucleotide) on NOS activity were similar in 'core' and 'penumbral' regions in control and sham groups. However, after 24 h MCAO, cofactor addition preferentially increased NOS activity in the ischemic hemisphere. Cofactor addition in the pup also had a greater effect on enhancing NOS activity in all regions compared with the adult. Greater NOS activity in core regions in the rat pup, as in the adult, could in part, explain the increased vulnerability of that region to ischemia. NOS activity also can be influenced by the availability of cofactors and this effect may be greater in the immature animal.
AB - Our studies examined the hypothesis that the distribution of cerebral injury after a focal ischemic insult in the immature rat pup is associated with the regional distribution of nitric oxide synthase (NOS) activity and that differences in the vulnerability to ischemia between pup and adult might be related to differences in cofactor availability. We measured NOS activity in well-defined regions prone to become either core or penumbra in controls and at different times (end of occlusion, 0.5 h, and 24 h reperfusion) after middle cerebral artery occlusion (MCAO) from the right and left hemispheres in a 14- to 18-day-old rat pup filament model. Three groups of corresponding isoflurane sham controls were also included. 'Core' NOS activity for combined right and left hemispheres ranged from 113% to 217% more than 'penumbral' regions in control and sham groups. In the three MCAO groups, marked decreases in ischemic core and penumbral NOS activity were seen; however, core NOS remained higher than penumbral regions bilaterally. The effects of cofactor addition (10 μM tetrahydrobiopterin, 3 μM flavin adenine dinucleotide, and 3 μM flavin mononucleotide) on NOS activity were similar in 'core' and 'penumbral' regions in control and sham groups. However, after 24 h MCAO, cofactor addition preferentially increased NOS activity in the ischemic hemisphere. Cofactor addition in the pup also had a greater effect on enhancing NOS activity in all regions compared with the adult. Greater NOS activity in core regions in the rat pup, as in the adult, could in part, explain the increased vulnerability of that region to ischemia. NOS activity also can be influenced by the availability of cofactors and this effect may be greater in the immature animal.
UR - http://www.scopus.com/inward/record.url?scp=0032822818&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0032822818&partnerID=8YFLogxK
U2 - 10.1203/00006450-199910000-00006
DO - 10.1203/00006450-199910000-00006
M3 - Article
C2 - 10509358
SN - 0031-3998
VL - 46
SP - 390
EP - 400
JO - Pediatric Research
JF - Pediatric Research
IS - 4
ER -